Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INRange: Warfarin Timing
NCT02376803Phase 4Completed
- Sponsor
- University of Alberta
- Start
- Feb 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of warfarin in Atrial fibrillation (AFib), prosthetic valve thrombosis (PVT), deep vein thrombosis (DVT), pulmonary embolism (PE), thromboembolism, sponsored by University of Alberta. Started Feb 2015; status: completed.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)prosthetic valve thrombosis (PVT)deep vein thrombosis (DVT)pulmonary embolism (PE)thromboembolism
Beyond the preview
Go deeper on NCT02376803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376803.